Copertina

Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Arta Aliu, Daan H. C. A. Bosch, Daniel Keszthelyi, Ashkan Rezazadeh Ardabili, Jean‐Frederic Colombel, Rachel Sawyer, Hans Törnblom, Ailsa Hart, Daisy M. A. E. Jonkers, Marieke J. Pierik, Zlatan Mujagic
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Alimentary Pharmacology & Therapeutics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD—Authors' reply
di: Arta Aliu, et al.
Pubblicazione: (2024)

Review article: Prevention of inflammatory bowel disease—The path forward
di: Sérgio Bronze, et al.
Pubblicazione: (2024)

Analysis of Antroduodenal Motility in Patients With Hypermobility Spectrum Disorders/Hypermobile Ehlers–Danlos Syndrome
di: Kim W. E. Sweerts, et al.
Pubblicazione: (2025)

Letter: Is Enteric Neuropathy Absent in Hypermobility Spectrum Disorders/Hypermobile Ehler–Danlos Syndrome? Authors' Reply
di: Kim W. E. Sweerts, et al.
Pubblicazione: (2025)

Review article: Novel therapies in inflammatory bowel disease – An update for clinicians
di: Nurulamin M. Noor, et al.
Pubblicazione: (2024)

Review article: Evidence‐based dietary management of inflammatory bowel disease
di: Peter R. Gibson, et al.
Pubblicazione: (2024)

Review article: Optimisation of biologic (monoclonal antibody) therapeutic response in inflammatory bowel disease
di: Thanaboon Chaemsupaphan, et al.
Pubblicazione: (2024)

Review article: The role of the gut–brain axis in inflammatory bowel disease and its therapeutic implications
di: Christy Riggott, et al.
Pubblicazione: (2024)

Editorial: Can we predict or not predict response to hypnotherapy? That is the question
di: Jenny Lövdahl, et al.
Pubblicazione: (2024)

Editorial: GLP‐1 receptor agonists in inflammatory bowel disease—Is it time?
di: Konstantinos Arvanitakis, et al.
Pubblicazione: (2024)

Meta‐analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease
di: Tsz Hong Yiu, et al.
Pubblicazione: (2024)

Editorial: Treatments for inflammatory bowel disease across the age‐spectrum—Are they the same?
di: Agnes Hiu Yan Ho, et al.
Pubblicazione: (2024)

Letter: Thioguanine, an under‐utilised option in inflammatory bowel disease? Authors' reply
di: Abhinav Vasudevan, et al.
Pubblicazione: (2024)

Letter: Allostatic load—A potential key in the development of inflammatory bowel disease
di: Maryam Kharal, et al.
Pubblicazione: (2024)

Allostatic load increases the incidence and risk of adverse prognosis in inflammatory bowel disease
di: Jianhui Zhao, et al.
Pubblicazione: (2024)

Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease—authors' reply
di: Abhinav Vasudevan, et al.
Pubblicazione: (2024)

Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors
di: Matthew J. Townsend, et al.
Pubblicazione: (2024)

Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis‐associated inflammatory bowel disease (PSC‐IBD): A matched analysis from the Paediatric PSC Consortium
di: Amanda Ricciuto, et al.
Pubblicazione: (2024)

Systematic review: Methotrexate—A poorly understood and underused medication in inflammatory bowel disease
di: Léa Sequier, et al.
Pubblicazione: (2024)

Letter: Light in the lumen—The expanding role of intestinal ultrasound for functional symptoms in inflammatory bowel disease
di: R. M. Mathias, et al.
Pubblicazione: (2024)

Letter: Diet‐microbiome interactions in inflammatory bowel disease—Navigating towards individualised dietary strategies
di: Iris Barth, et al.
Pubblicazione: (2024)

Letter: Microbial manipulation for primary sclerosing cholangitis‐associated inflammatory bowel disease—hope on the horizon
di: D. Bogatic, et al.
Pubblicazione: (2024)

Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort Study
di: Carl Eriksson, et al.
Pubblicazione: (2024)

Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis‐associated inflammatory bowel disease?
di: Ayesha Shah, et al.
Pubblicazione: (2024)

Use of glucagon‐like peptide‐1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease
di: Aakash Desai, et al.
Pubblicazione: (2024)

The contribution of dietary advanced glycation end‐products and genetic risk in the development of inflammatory bowel disease: a prospective cohort study
di: Fangyuan Jiang, et al.
Pubblicazione: (2024)

Application of clinical decision support tools for predicting outcomes with vedolizumab therapy in patients with inflammatory bowel disease: A KASID multicentre study
di: Kyuwon Kim, et al.
Pubblicazione: (2024)

Treatment of inflammatory bowel disease with steroid‐sparing medications is age‐dependent – Results from a Danish nationwide cohort study, 2000–2018
di: Rie Louise Møller Nordestgaard, et al.
Pubblicazione: (2024)

Factors Associated With Abdominal Pain in Patients With Active and Quiescent Ulcerative Colitis: A Multicohort Study
di: Tom van Gils, et al.
Pubblicazione: (2024)

Letter: Irritable bowel syndrome and antibiotics
di: George F. Longstreth
Pubblicazione: (2024)

Inflammatory bowel disease in 2024 and beyond
di: Richard B. Gearry, et al.
Pubblicazione: (2024)

Letter: Irritable bowel syndrome and antibiotics—Authors' reply
di: Kyle Staller, et al.
Pubblicazione: (2024)

Review article: Diagnosis and management of laryngopharyngeal reflux
di: Amanda J. Krause, et al.
Pubblicazione: (2024)

Performance of bowel preparation quality scales in patients with Crohn's disease
di: Virginia Solitano, et al.
Pubblicazione: (2024)

Review article: Oesophageal disorders in chronic liver disease
di: Francisco Idalsoaga, et al.
Pubblicazione: (2024)

Review article: Evaluation and care of the critically ill patient with cirrhosis
di: Iva Kosuta, et al.
Pubblicazione: (2024)

Review article: advances in the diagnosis and management of anorectal motility disorders
di: Dariush Shahsavari, et al.
Pubblicazione: (2024)

Systematic Review of Published Guidelines: Recommendations for Exams Under Anaesthesia, Seton Insertion and Timing of Seton Removal for Perianal and Rectovaginal Fistulising Crohn's Disease
di: Edgard Medawar, et al.
Pubblicazione: (2026)

Worldwide population prevalence and impact of sub‐diagnostic gastrointestinal symptoms
di: Olafur S. Palsson, et al.
Pubblicazione: (2024)

Prevalence and Burden of Fatigue Across Disorders of Gut–Brain Interaction: Results From the Rome Foundation Global Epidemiology Study
di: Fleur Veldman, et al.
Pubblicazione: (2026)